1df7
From Proteopedia
(Difference between revisions)
Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
- | 1DF7 is a | + | 1DF7 is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DF7 OCA]. |
==Reference== | ==Reference== | ||
- | + | <ref group="xtra">PMID:10623528</ref><references group="xtra"/> | |
[[Category: Dihydrofolate reductase]] | [[Category: Dihydrofolate reductase]] | ||
[[Category: Mycobacterium tuberculosis]] | [[Category: Mycobacterium tuberculosis]] | ||
- | [[Category: Single protein]] | ||
[[Category: Athappilly, F.]] | [[Category: Athappilly, F.]] | ||
[[Category: Chitnumsub, P.]] | [[Category: Chitnumsub, P.]] | ||
Line 43: | Line 42: | ||
[[Category: Tuberculosis]] | [[Category: Tuberculosis]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 22:35:50 2009'' |
Revision as of 20:35, 17 February 2009
DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND METHOTREXATE
Template:ABSTRACT PUBMED 10623528
About this Structure
1DF7 is a 1 chain structure of sequence from Mycobacterium tuberculosis. Full crystallographic information is available from OCA.
Reference
- Li R, Sirawaraporn R, Chitnumsub P, Sirawaraporn W, Wooden J, Athappilly F, Turley S, Hol WG. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs. J Mol Biol. 2000 Jan 14;295(2):307-23. PMID:10623528 doi:http://dx.doi.org/10.1006/jmbi.1999.3328
Page seeded by OCA on Tue Feb 17 22:35:50 2009
Categories: Dihydrofolate reductase | Mycobacterium tuberculosis | Athappilly, F. | Chitnumsub, P. | Hol, W G. | Li, R. | Sirawaraporn, R. | Sirawaraporn, W. | Turley, S. | Wooden, J. | Folateanalog | Methotrexate | Nicotinamide adenine dinucleotide | Rossmann fold | Structure-based inhibitor design | Tuberculosis